Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis M Luttrell

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
Methods in Enzymology|February 5, 2013
Biasing the parathyroid hormone receptor: relating in vitro ligand efficacy to in vivo biological activityKathryn M Appleton, Mi-Hye Lee, Christian Alele, et al.
Molecular Endocrinology (Baltimore, Md.)|April 15, 2015
Inhibition of Sphingosine Kinase 1 Ameliorates Angiotensin II-Induced Hypertension and Inhibits Transmembrane Calcium Entry via Store-Operated Calcium ChannelParker C Wilson, Wayne R Fitzgibbon, Sara M Garrett, et al.
Journal of Medical Genetics|June 5, 2010
Genetic variant in the promoter of connective tissue growth factor gene confers susceptibility to nephropathy in type 1 diabetesBing Wang, Rickey E Carter, Miran A Jaffa, et al.
Methods (San Diego, Calif.)|May 20, 2015
Informatic deconvolution of biased GPCR signaling mechanisms from in vivo pharmacological experimentationStuart Maudsley, Bronwen Martin, Jonathan Janssens, et al.
Nature|March 24, 2016
The conformational signature of β-arrestin2 predicts its trafficking and signalling functionsMi-Hye Lee, Kathryn M Appleton, Erik G Strungs, et al.
Diabetes Care|February 1, 2018
Plasma Connective Tissue Growth Factor (CTGF/CCN2) Levels Predict Myocardial Infarction in the Veterans Affairs Diabetes Trial (VADT) CohortKelly J Hunt, Miran A Jaffa, Sara M Garrett, et al.
The Journal of Biological Chemistry|May 11, 2013
The arrestin-selective angiotensin AT1 receptor agonist [Sar1,Ile4,Ile8]-AngII negatively regulates bradykinin B2 receptor signaling via AT1-B2 receptor heterodimersParker C Wilson, Mi-Hye Lee, Kathryn M Appleton, et al.
The Journal of Biological Chemistry|April 20, 2011
The beta-arrestin pathway-selective type 1A angiotensin receptor (AT1A) agonist [Sar1,Ile4,Ile8]angiotensin II regulates a robust G protein-independent signaling networkRyan T Kendall, Erik G Strungs, Saleh M Rachidi, et al.
The Journal of Biological Chemistry|December 11, 2002
The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activationAkira Tohgo, Eric W Choy, Diane Gesty-Palmer, et al.
The Journal of Biological Chemistry|May 31, 2002
Selective inhibition of heterotrimeric Gs signaling. Targeting the receptor-G protein interface using a peptide minigene encoding the Galpha(s) carboxyl terminusDavid S Feldman, A Musa Zamah, Kristen L Pierce, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Methods in Enzymology|February 5, 2013
Biasing the parathyroid hormone receptor: relating in vitro ligand efficacy to in vivo biological activityKathryn M Appleton, Mi-Hye Lee, Christian Alele, et al.
Molecular Endocrinology (Baltimore, Md.)|April 15, 2015
Inhibition of Sphingosine Kinase 1 Ameliorates Angiotensin II-Induced Hypertension and Inhibits Transmembrane Calcium Entry via Store-Operated Calcium ChannelParker C Wilson, Wayne R Fitzgibbon, Sara M Garrett, et al.
Journal of Medical Genetics|June 5, 2010
Genetic variant in the promoter of connective tissue growth factor gene confers susceptibility to nephropathy in type 1 diabetesBing Wang, Rickey E Carter, Miran A Jaffa, et al.
Methods (San Diego, Calif.)|May 20, 2015
Informatic deconvolution of biased GPCR signaling mechanisms from in vivo pharmacological experimentationStuart Maudsley, Bronwen Martin, Jonathan Janssens, et al.
Nature|March 24, 2016
The conformational signature of β-arrestin2 predicts its trafficking and signalling functionsMi-Hye Lee, Kathryn M Appleton, Erik G Strungs, et al.
Diabetes Care|February 1, 2018
Plasma Connective Tissue Growth Factor (CTGF/CCN2) Levels Predict Myocardial Infarction in the Veterans Affairs Diabetes Trial (VADT) CohortKelly J Hunt, Miran A Jaffa, Sara M Garrett, et al.
The Journal of Biological Chemistry|May 11, 2013
The arrestin-selective angiotensin AT1 receptor agonist [Sar1,Ile4,Ile8]-AngII negatively regulates bradykinin B2 receptor signaling via AT1-B2 receptor heterodimersParker C Wilson, Mi-Hye Lee, Kathryn M Appleton, et al.
The Journal of Biological Chemistry|April 20, 2011
The beta-arrestin pathway-selective type 1A angiotensin receptor (AT1A) agonist [Sar1,Ile4,Ile8]angiotensin II regulates a robust G protein-independent signaling networkRyan T Kendall, Erik G Strungs, Saleh M Rachidi, et al.
The Journal of Biological Chemistry|December 11, 2002
The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activationAkira Tohgo, Eric W Choy, Diane Gesty-Palmer, et al.
The Journal of Biological Chemistry|May 31, 2002
Selective inhibition of heterotrimeric Gs signaling. Targeting the receptor-G protein interface using a peptide minigene encoding the Galpha(s) carboxyl terminusDavid S Feldman, A Musa Zamah, Kristen L Pierce, et al.
Pageof 11